Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits
CORRECTING and REPLACING Humana Announces Major Expansion of Florida Dental Network, Benefits


First bullet point under More Help for Floridians Eligible for Both Medicare and Medicaid section of release dated October 17, 2022, should read: Healthy Options Allowance provides eligible members

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot: https://mms.businesswire.com/media/20221011005304/en/1597268/5/WG_Extraction%2B_5x4.jpg
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot


Waters Corporation (NYSE:WAT) today introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological

Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations: https://mms.businesswire.com/media/20221010005204/en/1596329/5/Mental_health_Humana_Foundation.jpg
Humana Foundation Invests $13 Million in Health Equity Innovation and Creating Healthy Emotional Connections for Vulnerable Populations


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, today announced the first grants reflecting its elevated focus on advancing health equity and improving

Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford: https://mms.businesswire.com/media/20221007005094/en/1595143/5/LiamLeanneWaters.jpg
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford


Waters Corporation (NYSE: WAT) today announced a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development

Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung: https://mms.businesswire.com/media/20221004005387/de/1590800/5/Warriors_Ava_%26_Rebecca_Dexcom_G7%5B1%5D.jpg
Markteinführung des Dexcom G7 in Großbritannien, Irland, Deutschland, Österreich und Hongkong – Start des globalen Rollouts des weltweit leistungsstärksten Systems zur kontinuierlichen Blutzuckerüberwachung


DexCom, Inc. (Nasdaq: DXCM), der weltweit führende Anbieter von Systemen zur kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, gab heute die Einführung des Dexcom G7 Systems

Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System: https://mms.businesswire.com/media/20221004005386/en/1590800/5/Warriors_Ava_%26_Rebecca_Dexcom_G7%5B1%5D.jpg
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System


DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now

ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members: https://mms.businesswire.com/media/20221001005004/en/1589832/5/AEP_Quote_-_George_Renaudin.jpg
ADDING MULTIMEDIA Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members


Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its

Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis: https://mms.businesswire.com/media/20220929005711/en/1587282/5/DHR-Powder_6b-Flow-Samples_Overall.jpg
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis


Waters Corporation (NYSE:WAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder

EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital: https://mms.businesswire.com/media/20220927006047/en/1584747/5/AcadiaHealthcareHenryFordHealthGroundbreaking.jpg
Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital


Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a

Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility: https://mms.businesswire.com/media/20220926005707/en/1582828/5/DJI_0884_%281%29.jpg
Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility


Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, today announced its newly built Precision Chemical Manufacturing Facility in Taunton, Mass. has achieved LEED

AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 millionhttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million
AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million
Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business: https://mms.businesswire.com/media/20220914005293/en/1571136/5/Kahn_photo.jpg
Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr

DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
Humana Finalizes Launch of CenterWell Home Health
Humana Finalizes Launch of CenterWell Home Health


Humana Inc. (NYSE: HUM) has announced the completion of its initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. With today’s announcement, CenterWell

CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix
CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix


CenterWell Senior Primary Care will open nine new senior-focused primary care centers in the Phoenix area through early 2023, marking the company’s debut in the Arizona market, giving local seniors

AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022: https://mms.businesswire.com/media/20220816005068/en/1543852/5/GN_Logo_RGB_300ppi.jpg
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise
GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise


GN Hearing, the global leader in hearing aid innovation, today announces the launch of ReSound OMNIA – a new hearing aid platform that will set a new standard in hearing technology and improve how

STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer

DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics